These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26109386)

  • 1. Developing Peripheral Blood Gene Expression-Based Diagnostic Tests for Coronary Artery Disease: a Review.
    Rhees B; Wingrove JA
    J Cardiovasc Transl Res; 2015 Aug; 8(6):372-80. PubMed ID: 26109386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid arthritis complicates noninvasive whole blood gene expression testing for coronary artery disease.
    Jessee R; Peart E; Beineke P; Rosenberg S; Wingrove JA; Kraus WE; Huffman KM
    Am Heart J; 2017 Oct; 192():13-18. PubMed ID: 28938959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gender-specific blood-based gene expression score for assessing obstructive coronary artery disease in nondiabetic patients: results of the Personalized Risk Evaluation and Diagnosis in the Coronary Tree (PREDICT) trial.
    Lansky A; Elashoff MR; Ng V; McPherson J; Lazar D; Kraus WE; Voros S; Schwartz RS; Topol EJ
    Am Heart J; 2012 Sep; 164(3):320-6. PubMed ID: 22980297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical utility of gene expression testing on the diagnostic evaluation of patients presenting to the cardiologist with symptoms of suspected obstructive coronary artery disease: results from the IMPACT (Investigation of a Molecular Personalized Coronary Gene Expression Test on Cardiology Practice Pattern) trial.
    McPherson JA; Davis K; Yau M; Beineke P; Rosenberg S; Monane M; Fredi JL
    Crit Pathw Cardiol; 2013 Jun; 12(2):37-42. PubMed ID: 23680805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Expression Signatures and the Spectrum of Coronary Artery Disease.
    Friede KA; Ginsburg GS; Voora D
    J Cardiovasc Transl Res; 2015 Aug; 8(6):339-52. PubMed ID: 26089288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis.
    Marchetti G; Girelli D; Zerbinati C; Lunghi B; Friso S; Meneghetti S; Coen M; Gagliano T; Guastella G; Bochaton-Piallat ML; Pizzolo F; Mascoli F; Malerba G; Bovolenta M; Ferracin M; Olivieri O; Bernardi F; Martinelli N
    Thromb Haemost; 2015 Mar; 113(3):655-63. PubMed ID: 25374339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weighted gene co-expression network analysis identifies specific modules and hub genes related to coronary artery disease.
    Liu J; Jing L; Tu X
    BMC Cardiovasc Disord; 2016 Mar; 16():54. PubMed ID: 26944061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of coronary artery disease: the promise of the transcriptome.
    Siemelink MA; Zeller T
    Curr Cardiol Rep; 2014 Aug; 16(8):513. PubMed ID: 24950674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene profiling identifies secreted protein transcripts from peripheral blood cells in coronary artery disease.
    Ma J; Liew CC
    J Mol Cell Cardiol; 2003 Aug; 35(8):993-8. PubMed ID: 12878486
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of exercise stress testing on diagnostic gene expression in patients with obstructive and nonobstructive coronary artery disease.
    Filsoof DM; Safford RE; Newby K; Rosenberg S; Kontras DG; Baker A; Odunukan OW; Fletcher G
    Am J Cardiol; 2015 May; 115(10):1346-50. PubMed ID: 25776454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential leucocyte RNA expression in the coronary arteries compared to systemic circulation discriminates between patients with and those without coronary artery disease.
    Ribalta J; Alipour A; Sánchez-Cabo F; Vallvé JC; Njo T; Álvarez R; Janssen H; Liem A; Dopazo A; Castro-Cabezas M
    Clin Investig Arterioscler; 2017; 29(2):60-66. PubMed ID: 28188023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of CD133-positive cells in coronary artery disease.
    Li J; Zhou C; Li J; Wan Y; Li T; Ma P; Wang Y; Sang H
    Mol Med Rep; 2015 Nov; 12(5):7512-6. PubMed ID: 26458356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events.
    Healy AM; Pickard MD; Pradhan AD; Wang Y; Chen Z; Croce K; Sakuma M; Shi C; Zago AC; Garasic J; Damokosh AI; Dowie TL; Poisson L; Lillie J; Libby P; Ridker PM; Simon DI
    Circulation; 2006 May; 113(19):2278-84. PubMed ID: 16682612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating FABP4 is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individuals.
    Reiser H; Klingenberg R; Hof D; Cooksley-Decasper S; Fuchs N; Akhmedov A; Zoller S; Marques-Vidal P; Marti Soler H; Heg D; Landmesser U; Rodondi N; Mach F; Windecker S; Vollenweider P; Matter CM; Lüscher TF; von Eckardstein A; Gawinecka J
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1872-9. PubMed ID: 26069234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of microRNA expression profiling with genome-wide SNP genotyping to construct a coronary artery disease-related miRNA-miRNA synergistic network.
    Hua L; Xia H; Zhou P; Li D; Li L
    Biosci Trends; 2014 Dec; 8(6):297-307. PubMed ID: 25641175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.
    Tabuchi T; Satoh M; Itoh T; Nakamura M
    Clin Sci (Lond); 2012 Aug; 123(3):161-71. PubMed ID: 22364258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of a genomic-based, personalized medicine test in patients presenting with symptoms suggesting coronary artery disease.
    Herman L; Froelich J; Kanelos D; St Amant R; Yau M; Rhees B; Monane M; McPherson J
    J Am Board Fam Med; 2014; 27(2):258-67. PubMed ID: 24610188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Toll-like receptor 4-responsive microRNA panel in patients with coronary artery disease: results from prospective and randomized study of treatment with renin-angiotensin system blockade.
    Satoh M; Takahashi Y; Tabuchi T; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
    Clin Sci (Lond); 2015 Apr; 128(8):483-91. PubMed ID: 25385173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic potential of differentially expressed Homer1, IL-1β, and TNF-α in coronary artery disease.
    Jing X; Chen SS; Jing W; Tan Q; Yu MX; Tu JC
    Int J Mol Sci; 2014 Dec; 16(1):535-46. PubMed ID: 25551602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cis and trans effects of the risk variants of coronary artery disease in the Chr9p21 region.
    Zhao W; Smith JA; Mao G; Fornage M; Peyser PA; Sun YV; Turner ST; Kardia SL
    BMC Med Genomics; 2015 May; 8():21. PubMed ID: 25958224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.